CNR Institutional Research Information System

ZUCCA, FABIO ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.195
NA - Nord America 1.243
SA - Sud America 434
EU - Europa 401
AF - Africa 37
OC - Oceania 3
Totale 4.313
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.178
SG - Singapore 906
CN - Cina 528
BR - Brasile 353
VN - Vietnam 274
HK - Hong Kong 204
FR - Francia 142
KR - Corea 85
IT - Italia 67
IN - India 54
DE - Germania 43
CA - Canada 32
JP - Giappone 32
GB - Regno Unito 30
AR - Argentina 28
BD - Bangladesh 26
FI - Finlandia 26
MX - Messico 18
ID - Indonesia 17
EC - Ecuador 14
NL - Olanda 14
CO - Colombia 12
ZA - Sudafrica 12
RU - Federazione Russa 11
ES - Italia 10
IL - Israele 10
IQ - Iraq 8
VE - Venezuela 8
MA - Marocco 7
PY - Paraguay 7
UA - Ucraina 7
PE - Perù 6
TR - Turchia 6
AZ - Azerbaigian 5
KE - Kenya 5
PL - Polonia 5
PT - Portogallo 5
SA - Arabia Saudita 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
IE - Irlanda 4
JO - Giordania 4
MY - Malesia 4
PA - Panama 4
RS - Serbia 4
SE - Svezia 4
CZ - Repubblica Ceca 3
LU - Lussemburgo 3
NP - Nepal 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
AT - Austria 2
CL - Cile 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
YT - Mayotte 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
BY - Bielorussia 1
DJ - Gibuti 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
KG - Kirghizistan 1
LV - Lettonia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
QA - Qatar 1
TG - Togo 1
TZ - Tanzania 1
Totale 4.313
Salva come PNG Salva come JPEG
Città #
Singapore 522
Santa Clara 406
Hefei 220
Hong Kong 198
San Jose 178
Ho Chi Minh City 104
Beijing 100
Lauterbourg 91
Seoul 84
Ashburn 83
Hanoi 59
Los Angeles 35
Dallas 29
São Paulo 27
Frankfurt am Main 22
New York 19
Tokyo 19
Guangzhou 18
Helsinki 17
Mumbai 12
Rio de Janeiro 12
Atlanta 11
Buffalo 11
Milan 11
Biên Hòa 10
Da Nang 10
Orem 10
Bengaluru 9
Minamishinagawa 9
Portsmouth 9
Brasília 8
Johannesburg 8
Belo Horizonte 7
Boston 7
Brooklyn 7
Guayaquil 7
Houston 7
Quận Bình Thạnh 7
Turku 7
Brescia 6
Curitiba 6
Düsseldorf 6
Guarulhos 6
Haiphong 6
Arese 5
Baku 5
Chicago 5
Duque de Caxias 5
Madrid 5
Manaus 5
Nuremberg 5
Phoenix 5
Porto Alegre 5
Ribeirão Preto 5
Salvador 5
Amman 4
Asunción 4
Birmingham 4
Buenos Aires 4
Campinas 4
Can Tho 4
Chennai 4
Dublin 4
Goiânia 4
Hyderabad 4
Kolkata 4
Las Vegas 4
Lima 4
Nairobi 4
Phillipsburg 4
Queens 4
Springfield 4
The Bronx 4
Bandung 3
Bexley 3
Bogotá 3
Bắc Giang 3
Calgary 3
Delhi 3
Denver 3
Dhaka 3
Elk Grove Village 3
Erbil 3
Falkenstein 3
Formosa 3
Hamilton 3
Kuala Lumpur 3
Lisbon 3
Luxembourg 3
Maceió 3
Manchester 3
Marseille 3
Milwaukee 3
Montreal 3
Monza 3
Munich 3
New London 3
Ninh Bình 3
Nitrianske Hrnčiarovce 3
Nova Iguaçu 3
Totale 2.648
Salva come PNG Salva come JPEG
Nome #
Engineered nanoparticles. How brain friendly is this new guest? 105
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals 93
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease 87
Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. 83
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease 83
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease 80
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders 73
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells 71
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease 70
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role 68
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease 65
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects 64
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 61
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain 61
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models 60
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease 59
The role of neuromelanins in the oxidative stress of Parkinson's disease. 58
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease 58
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells 56
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease 55
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease 55
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus 55
Convenient Synthetic Method Of Putative Degradative Markers To Identify Various Catecholic Metabolites In Addition To Dopamine And Norepinephrine Incorporated In Neuromelanin. 53
Neuromelanin a chelator of iron and other metals in catecholaminergic neurons of substantia nigra and locus coeruleus. 52
Neuromelanin of the Human Substantia Nigra: An Update 52
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases 51
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A 49
Neuromelanins Isolated from Different Regions of the Human Brain Exhibit a Common Surface Photoionization Threshold 48
Melanic Pigments in the Human brain 48
Synthetic models of neuromelanin with fibrillated protein in the core 47
A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest 47
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease 47
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. 46
Contrast mechanisms associated with neuromelanin-MRI 46
Neuromelanin organelle pathways in aging and neurodegeneration of Parkinson's Disease 46
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease 45
IRON, COPPER AND THEIR MOLECULES IN SUBSTANTIA NIGRA OF NORMAL SUBJECTS DURING AGING 44
The role of neuromelanin organelle pathways in parkinson's disease 44
The Role of Iron in Neurodegeneration 44
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids. 44
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology 44
The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface. 43
Proteomic profile of neuromelanin and neuromelanin-containing organelles 43
NEUROMELANINS ACCUMULATE IN NEURONS DURING HUMAN BRAIN AGING AND BIND METALS 42
Neuromelanin organelles pathways in brain aging and Parkinson's disease 42
Neuromelanin activates microglia and induces substantia nigra neuron death. A key mechanism of Parkinson's disease. 42
Neuromelanins in brain aging and Parkinson's disease. 40
Protective and toxic roles of dopamine in Parkinson's disease 40
The structure of neuromelanin as studied by chemical degradative methods 39
The Neuromelanin of Human Substantia Nigra: Physiological and Pathogenic Aspects 39
Protective and neurotoxic role of neuromelanin in human brain 39
Protective and toxic role of neuromelanin in brain aging and Parkinson's disease 38
NEUROMELANIN ORGANELLES PATHWAYS AND NEURODEGENERATION IN PARKINSON'S DISEASE 38
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 38
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. 38
NEUROMELANIN ORGANELLES AND AUTOPHAGY IN BRAIN AGING 38
Application of Pump-Probe Imaging Towards Chemical and Structural Characterization of Neuromelanin. 37
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases 37
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry 35
α-Synuclein and Dopamine Metabolites DOPAL and DOPAC: A Pathway to New Synthetic Neuromelanin Models 34
Melanin-protein fibrils conjugates as models to study neuromelanin structure and reactivity. 34
Neuromelanin-sensitive MRI as a proxy-measure of dopamine function in neuropsychiatric illness. 32
Neuromelanin and metals in brain aging and neurodegeneration. 31
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 31
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes. 30
Neuromelanin and metals in brain aging and neurodegeneration. 30
Biosynthetic pathway to neuromelanin and its aging process 29
Neuromelanins, oxidative stress and Parkinson's disease 29
Neuromelanin in human brain: protective and toxic role. 29
The role of neuromelanin and iron in brain aging and Parkinson's disease. 29
Iron, copper and their proteins in substantia nigra of human brain during aging. 29
The role of neuromelanin in brain aging and neurodegeneration of Parkinson's disease 28
Effect of prolonged exposure to 50 Hz electric and magnetic fields on neurotransmitters in rat brain 27
The application of the Neutron Activation Analysis for trace metals determination in human brain tissues and substantia nigra neuromelanin. 27
The role of neuromelanin in brain aging and Parkinson's disease. 27
NEURONAL MHC-I DISPLAY IN T-CELL MEDIATED NEURODEGENERATION 27
Neuromelanin in the human brain: protective and toxic role. 27
Iron and copper molecules in aging of human substantia nigra. Consequences for neurodegenerative processes. 26
Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus 26
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 26
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration 26
The structure, synthesis and role of neuromelanins in brain aging and neurodegeneration 26
Neuromelanin activates microglia and induces substantia nigra neuron death. 26
Effect on neurotransmitters and receptors in rat exposed to 50Hz electric and magnetic fields from conception to adult life 25
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes 25
A modern imaging investigation of neuromelanin extracted from the substantia nigra region of the human brain. 24
Chemistry and biophysics of melanins 24
EXPRESSION OF MHC-I ON SUSBTANTIA NIGRA AND LOCUS COERULEUS OF HUMAN CONTROL and PARKINSON'S DISEASE SUBJECTS: IMPLICATIONS IN DOPAMINERGIC NEURONAL DEGENERATION 24
Activation of microglia by neuromelanin: correlation of neuromelanin phagocytosis and degradation, reactive oxygen species production, and ventral midbrain neuron death. 24
The role of neuromelanin in brain aging and Parkinson's disease. 24
Identification and quantification of dolichol and dolichoic acid in neuromelanin from substantia nigra of the human brain 24
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 23
Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference. 23
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 23
The neurodegenerative role of neuromelanin in Parkinson's disease 22
Iron, copper and zinc concentration in substantia nigra of human brain during aging. 22
The role of iron in brain ageing and neurodegenerative disorders 21
The role of neuromelanin in brain aging and Parkinson's disease. 21
Effetti dell'esposizione cronica a CEM di 50 Hz su neurotrasmettitori e recettori nel cervello di ratto 21
Neuromelanin of the substantia nigra: a neuronal black hole with protective and toxic characteristics 21
Totale 4.202
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.250
article - articoli 8.277
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 316
Totale 23.843
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202444 0 0 0 0 0 0 0 0 2 0 41 1
2024/20251.618 2 8 136 49 379 46 22 132 49 60 376 359
2025/20262.603 131 348 219 379 467 122 345 151 111 146 86 98
2026/2027125 125 0 0 0 0 0 0 0 0 0 0 0
Totale 4.390